Ifenprodil as a ReMyelinating repurpOsed Drug in Multiple Sclerosis
Ifenprodil as a ReMyelinating repurpOsed Drug in Multiple Sclerosis
Not yet recruiting · NCT06330077 · Registry updated 2024-03-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Ifenprodil as a ReMyelinating repurpOsed Drug in Multiple Sclerosis | CNS demyelinating autoimmune disease, autoimmune disease, autoimmune disorder of the nervous system, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder, relapsing-remitting multiple sclerosis | Not yet recruiting | Phase 2 | 2024-03-26 | NCT06330077 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 985 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Groupe Hospitalier Pitié Salpêtrière - APHP | Paris | France | 1 |
| Hôpital Neurologique Pierre WERTHEIMER - HCL | Bron | France | 1 |